Claire Chabaud-Rothschild

Claire is the CEO of Braave. She founded the company to build continuous cardiovascular and vasomotor monitoring into the bra.

Braave combines garment-embedded, clinical-grade sensing with clinical research to capture female physiology continuously between visits, starting with menopause and cardiovascular health. The company’s goal is to build the longitudinal physiological datasets clinicians and researchers have historically lacked, to better understand how women’s health changes over time and in response to treatment. Claire holds 31 patents in lingerie innovation and has worked with three of the world’s largest lingerie groups. She is an alumna of Sciences Po and UCLA and is based in Los Angeles.